Hezong Medicine Easy-To-Buy Pharmaceutical establishes a subsidiary, Shutan Artificial Intelligence
I'm PortAI, I can summarize articles.
Hezong Medicine Easy-To-Buy Pharmaceutical has established a wholly-owned subsidiary, Shutan Artificial Intelligence Technology Co., Ltd., with a registered capital of 10 million yuan, aimed at responding to the digital economy development policy. The company will integrate resources such as digital supply chains and intelligent procurement and sales systems, using AI, big data, and other technologies to build a SaaS digital comprehensive service platform, promoting the technological research and application of industry data resources
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments